MedTrace Logo

A Retrospective Review of Malignant Liver Tumors

NCT00728650 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 228

Last updated 2012-02-07

No results posted yet for this study

Summary

This study will review the treatment and outcomes of patients having primary and metastatic hepatic malignancies. Patients treated with surgical resection, percutaneous radiofrequency ablation (RFA), and transarterial chemoembolization (TACE) will be compared with patients not receiving these treatments. Tumor recurrence and survival data will be compared to the published literature to determine the efficacy of current treatment strategies in this patient population.

Conditions

Sponsors & Collaborators

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Thomas A Broughan, MD · University of Oklahoma-Tulsa

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-31
Primary Completion
2010-10-31
Completion
2011-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00728650 on ClinicalTrials.gov